In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes

Authors

Institutions

Publication Details

Journal
Antibiotics
Published
2026-04-07
DOI
https://doi.org/10.3390/antibiotics15040375
Primary Topic
Pneumonia and Respiratory Infections
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes

Mark Jones, Helio S. Sader, Rodrigo E. Mendes, Mariana Castanheira
Antibiotics
Pneumonia and Respiratory Infections
article

In Vitro Antimicrobial Activity of Ceftobiprole and Comparator Agents Against Streptococcus pneumoniae Responsible for Lower Respiratory Tract Infections in the United States (2016–2020), Including Resistant Subsets and Select Serotypes

Mark Jones, Helio S. Sader, Rodrigo E. Mendes, Mariana Castanheira
article en

Abstract

No abstract available for this paper.
AntibioticsVol. 15(4)
JMI Laboratories (US), Basilea Pharmaceutica (Switzerland) (CH)
U.S. Department of Health and Human Services
Good health and well-being
Openalex Percentile: Top 29%
Pneumonia and Respiratory Infections
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.